Tell us your exact objective and the specific bottlenecks you face. We deliver counter-intuitive, procurement-ready candidates.
Stop waiting months to synthesize theoretical compounds. Every candidate ORAKLIS isolates is cross-referenced with commercial catalogs. Order the physical vial today, test in-vitro immediately.
Target organisms and tumors mutate. We help you stay ahead. Our proprietary engine is designed to identify entirely new candidates that bypass existing patents and specific resistance mechanisms.
We do not need your structural data to operate. You simply provide us with the precise objective and the constraints to overcome (e.g., mutation resistance, dissolution issues). We calibrate our engine based on current scientific literature and return actionable intelligence.
Brief us on your target, your current bottlenecks, and the specific resistance mutations you need to circumvent.
We configure our proprietary screening engine against millions of commercially available molecules.
We provide a highly restricted selection of viable, procurement-ready candidates optimized for your exact parameters.
We believe in advancing critical healthcare. For purely therapeutic targets, ORAKLIS covers the screening fees. We work alongside your research team and request only in-vitro feedback and co-authorship/IP recognition upon success.
Submit a TargetFor commercial applications requiring absolute market dominance. You pay a premium access fee to lock our engine on your specific target, ensuring 100% transfer of Intellectual Property and total exclusivity.
Request a Quote